Document Type : original article

Authors

1 Student Research Committee, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

2 Ghaemieh health care center, Mazandaran University of Medical Sciences, Sari,Iran.

3 Department of Pediatrics, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

4 Department of Nephrology, Hormozgan University of Medical Sciences, Bandar-Abbas, Iran

5 Department of Neuroscience, university of California San Diego, California, United State Amarica.

6 Student Research Committee , Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Abstract

Background: Shigella is a gram-negative, facultative anaerobic, nonperforming, nonmotile and rod-shaped bacterium that causes mucoid bloody diarrhea, known as dysentery or shigellosis. This study aimed to determine the prevalence of Shigella species and the antibiotic resistance pattern of Shigella species isolated from children with acute diarrhea in Bandar Abbas Pediatric Hospital, south of Iran.
Method: This descriptive and retrospective study was conducted based on the patients’ information in their checklists, including age, gender, Shigella culture results, Shigella species, cessation of fever, city of residence, duration of symptoms before hospitalization, antibiotic use in the previous two weeks, degree of fever at the time of hospitalization, vomiting, convulsions, dehydration, death, frequency of diarrhea, and loss of blood in feces.
Results: Out of 162 patients, 82 (50.62%) were females, and 80 (49.38%) were males. Cultures of 46 patients (28.39%) were infected with Shigella flexneri species, 6 patients (3.72%) with Shigella boydii species, and 56 patients (34.58%) with Shigella sonnei species. Tetracycline had the highest rate of resistance (88.8%), and ciprofloxacin had the lowest resistance (7.41%).
Conclusion: The pattern of common Shigella species has changed from S. flexneri to S. sonnei in recent years. The pattern of antibiotic resistance among these species is also changing; so regular investigation of the prevalence of different species and their drug resistance pattern is necessary to make a correct decision about the appropriate treatment.

Keywords

  1. Respress E, Evener SL, Caruso E, Jacobson K, Bowen A, Kachur RE, Garcia-Williams AG, Wright ER. Preferences for Shigellosis-Related Health Promotion Materials for Gay, Bisexual, and Other Men Who Have Sex With Men: Results From a Qualitative Assessment, Atlanta, GA. Sexually Transmitted Diseases. 2022; 49(4):304-9.
  2. Williams P, Berkley J. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Pediatrics and international child health. 2018; 38 (sup1): S50–S65. Epub 2018/05/24. https://doi. org/10.1080/20469047.2017. 1409454 PMID: 29790845.
  3. Behruznia P, Sadredinamin M, Hashemi A, Hajikhani B, Yousefi Nojookambari N, Behruznia M, Ghalavand Z. Decreased Susceptibility of Shigella Isolates to Azithromycin in Children in Tehran, Iran. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022; 2022.
  4. Zhang J, Jin H, Hu J, Yuan Z, Shi W, Yang X, Xu X, Meng J. Antimicrobial resistance of Shigella spp. from humans in Shanghai, China, 2004–2011. Diagnostic microbiology and infectious disease. 2014; 78(3):282-6.
  5. Klontz KC, Singh N. Treatment of drug-resistant Shigella infections. Expert review of anti-infective therapy. 2015; 13(1):69-80.
  6. Sah SK, Basnet S, Shrestha S, Ghale K, Tamang S, Mandal DK, Bahadur Pun S. Burden of Shigella spp and Vibrio spp, and their antibiotic sensitivity pattern in the patients with acute gastroenteritis in tertiary care hospital in Nepal. BMC Res Notes. 2019; 12(1):699.
  7. Gebreegziabher G, Asrat D, Y WA, Hagos T. Isolation and Antimicrobial Susceptibility Profile of Shigella and Salmonella Species from Children with Acute Diarrhoea in Mekelle Hospital and Semen Health Center, Ethiopia. Ethiop J Health Sci. 2018; 28(2):197-206.
  8. Farsiani H, Sasan MS. High rate of resistance to ceftriaxone and azithromycin among Shigella spp. isolates at three children's referral hospitals in Northeast Iran. Journal of Infection and Chemotherapy. 2020; 26(9):955-8.
  9. O’Flanagan H, Siddiq M, Llewellyn C, Richardson D. Antimicrobial resistance in sexually transmitted Shigella in men who have sex with men: A systematic review. International journal of STD & AIDS. 2023; 34(6):374-84.
  10. de Souza ZN, de Moura DF, de Almeida Campos LA, Córdula CR, Cavalcanti IMF. Antibiotic resistance profiles on pathogenic bacteria in the Brazilian environment. Archives of Microbiology. 2023; 205(5):185.
  11. Pakbin B, Amani Z, Allahyari S, Mousavi S, Mahmoudi R, Brück WM, Peymani A. Genetic diversity and antibiotic resistance of Shigella spp. isolates from food products. Food Sci Nutr. 2021; 9(11):6362-71.
  12. Vubil D, Balleste-Delpierre C, Mabunda R, Acácio S, Garrine M, Nhampossa T, Alonso P, Mandomando I, Vila J. Antibiotic resistance and molecular characterization of shigella isolates recovered from children aged less than 5 years in Manhiça, Southern Mozambique. Int J Antimicrob Agents. 2018; 51(6):881-7.
  13. Khan SU, Aslam R, Ashraf M, Ali S, Saqib M, Khattak MA, Khattak US, Amanullah H, Wuryastuty H, Wasito R, Haryanto A, Ullah F, Ma M, Ali S. Prevalence of antibiotic resistance pattern in shigella isolates procured from pediatric patients at Faisalabad - Pakistan. Pak J Pharm Sci. 2022; 35(1):41-8.
  14. Nuzhat S, Das R, Das S, Islam SB, Palit P, Haque MA, Chakraborty S, Hossain Khan S, Ahmed D, Alam B, Ahmed T, Jobayer Chisti M, A S G Faruque. Antimicrobial resistance in shigellosis: A surveillance study among urban and rural children over 20 years in Bangladesh. Plos one. 2022; 17(11):e0277574.
  15. Bian F, Yao M, Fu H, Yuan G, Wu S, Sun Y. Resistance characteristics of CTX-M type Shigella flexneri in China. Bioscience Reports. 2019; 39(9).
  16. Terfassa A, Jida M. Prevalence and antibiotics susceptibility pattern of Salmonella and Shigella species among diarrheal patients attending Nekemte Referral Hospital, Oromia, Ethiopia. International journal of microbiology. 2018; 2018.
  17. Tribble DR. Antibiotic therapy for acute watery diarrhea and dysentery. Military medicine. 2017; 182(suppl_2):17-25.
  18. Rahbar M, Deldari M, Hajia M. Changing prevalence and antibiotic susceptibility patterns of different Shigella species in Tehran, Iran. The Internet J Microbiol. 2007; 3(2).
  19. Chiou C-S, Izumiya H, Kawamura M, Liao Y-S, Su Y-S, Wu H-H, Chen W-C, Lo Y-C. The worldwide spread of ciprofloxacin-resistant Shigella sonnei among HIV-infected men who have sex with men, Taiwan. Clinical Microbiology and Infection. 2016; 22(4):383. e11-. e16.
  20. Barari Skr, Ahmadpour Km. Prevalence of Shigella species and their antimicrobial resistance patterns at Amirkola children's hospital, North of Iran. 2007.
  21. Pazhani GP, Niyogi SK, Singh AK, Sen B, Taneja N, Kundu M, Yamasaki S, Ramamurthy T. Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India. Journal of medical microbiology. 2008; 57(7):856-63.
  22. Zayet S, Klopfenstein T, Pierron A, Royer P-Y, Toko L, Garnier P, Gendrin V. Shigella sonnei, an emerging multidrug-resistant sexually transmitted pathogen in Franche-Comté, France. Emerging Microbes & Infections. 2021; 10(1):1702-5.
  23. Ma Q, Huang Y, Wang J, Xu X, Hawkey J, Yang C, Liang B, Hu X, Wu F, Yang X, Wang J, Li R, Li P, Xie J, Jia L, Wang L, Hao R, Tong Y, Holt KE, Qiu S, Sun Y, Song H. Multidrug-resistant Shigella sonnei carrying the plasmid-mediated mcr-1 gene in China. International journal of antimicrobial agents. 2018; 52(1):14-21.
  24. Ap Seribelli A, Fraz MR, Medeiros MIC, Stehling EG, Falc JP. Molecular typing and occurrence of beta-lactam resistance genes of Shigella sonnei strains isolated from 1983 to 2014 in the S o Paulo state of Brazil. Microbiology and immunology. 2017; 61(12):547-53.
  25. Gharpure R, Friedman CR, Fialkowski V, Collins JP, Strysko J, Marsh ZA, Chen JC, Meservey EH, Adediran AA, Schroeder MN, Wadhwa A, Fullerton KE, Watkins LF. Azithromycin and ciprofloxacin treatment outcomes during an outbreak of multidrug-resistant Shigella sonnei infections in a retirement community—Vermont, 2018. Clinical Infectious Diseases. 2022; 74(3):455-60.
  26. Avakh Majalan P, Hajizade A, Nazarian S, Pourmand MR, Amiri Siyavoshani K. Investigating the Prevalence of Shigella Species and Their Antibiotic Resistance Pattern in Children With Acute Diarrhea Referred to Selected Hospitals in Tehran, Iran. Journal of Applied Biotechnology Reports. 2018; 5(2):70-4.
  27. Ranjbar R. soltandallal MM, Talebi M, Pourshafie MR. Increased isolation and characterization of Shigellasonnei obtained from hospitalized children in Tehran. Iran J Health Popul Nutr. 2008; 26(4):426-30.
  28. Gu B, Xu T, Kang H, Xu Y, Liu G, Pan S, Qian H, Ma P. A 10-year surveillance of antimicrobial susceptibility patterns in Shigella sonnei isolates circulating in Jiangsu Province, China. Journal of global antimicrobial resistance. 2017; 10:29-34.
  29. Kaur G, Sathyabama S, Arora A, Verma S, Mubin N, Agrewala JN, Mayilraj S. Genome sequencing, annotation and comparative genomic analysis of Shigella dysenteriae strain SD1D. Gut Pathog. 2014; 6:28.
  30. Qiu L, Wang H, Wang X. Conversion mechanism of heptachlor by a novel bacterial strain. RSC Adv. 2018; 8(11):5828-39.
  31. Ranjbar R, Farahani A. Shigella: antibiotic-resistance mechanisms and new horizons for treatment. Infection and drug resistance. 2019:3137-67.
  32. Shogbesan O, Rettew A, Shaikh B, Abdulkareem A, Donato A. Shigella sonnei Bacteremia Presenting with Profound Hepatic Dysfunction. Case Rep Gastrointest Med. 2017; 2017:7293281.
  33. Eftekhari N, Bakhshi B, Pourshafie MR, Zarbakhsh B, Rahbar M, Hajia M, Ghazvini K. Genetic diversity of Shigella spp. and their integron content. Foodborne pathogens and disease. 2013; 10(3):237-42.
  34. Ghaemi EO, Aslani MM, Moradi AV, Dadgar T, Livani S, Mansourian AR, Bakhshande Nosrat S, Ahmadi AR. Epidemiology of Shigella-associated diarrhea in Gorgan, north of Iran. Saudi Journal of Gastroenterology. 2007; 13(3):129-32.